Looking beyond VEGF to target BRB dysfunction in DME: Novel approaches to prevent vision loss
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to provide more durable vision protection.
The expert:
Dr. Diana Do, Stanford University School of Medicine, Palo Alto, CA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.